SCHEMBL25002959

SCHEMBL25002959

COc1cc(/C=N/NC(=O)c2cc(-c3ccc(Cl)cc3)ccn2)cc(OC)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AMY1A P0DUB6 3/20 0.50
▸ MGAM O43451 1/20 0.47
▸ KMT2A Q03164 5/20 0.47
▸ POLB P06746 4/20 0.47
▸ MEN1 O00255 4/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ HPGD P15428 2/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ MAPT P10636 4/20 0.45
▸ GAA P10253 1/20 0.45
▸ NPC1 O15118 3/20 0.45
▸ RAB9A P51151 3/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ SCN2A Q99250 1/20 0.44
▸ SCN10A Q9Y5Y9 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27237399 1.00 AMY1A (0.50) AMY1AMGAMKMT2APOLBMEN1
SCHEMBL30862203 1.00 AMY1A (0.50) AMY1AMGAMKMT2APOLBMEN1
SCHEMBL27237453 0.87 ALDH1A1 (0.49) MGAMKMT2APOLBMEN1ALDH1A1
SCHEMBL25002957 0.87 ALDH1A1 (0.49) MGAMKMT2APOLBMEN1ALDH1A1
SCHEMBL30862206 0.87 ALDH1A1 (0.49) MGAMKMT2APOLBMEN1ALDH1A1
SCHEMBL27237430 0.86 HDAC6 (0.53) AMY1AMGAMKMT2APOLBMEN1
SCHEMBL25003164 0.86 HDAC6 (0.53) AMY1AMGAMKMT2APOLBMEN1
SCHEMBL27237472 0.86 KMT2A (0.49) AMY1AMGAMKMT2APOLBMEN1
SCHEMBL27237467 0.86 KMT2A (0.49) AMY1AMGAMKMT2APOLBMEN1
SCHEMBL25003163 0.85 GCGR (0.50) AMY1AMGAMKMT2APOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4382101-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS Eurofarma Laboratórios S.A. (BR) 2024-06-12 — — EP claimed
EP-4382101-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS Eurofarma Laboratórios S.A. (BR) 2024-06-12 — — EP disclosed
WO-2023010192-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 — — WO disclosed
Send feedback